Connect your AI

Balchem BCPC Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

International Flavors & FragrancesIFF

$167M+8.4%

AbbottABT

$1.2B+53.1%

Merck & Co.MRK

$4.13B+35.0%

AVT

AvantorAVTR

——

ZoetisZTS

——

Other financials

Income statement

Revenue$270.7M+8.1%

Gross profit$101.1M+14.6%

Operating income$55.6M+9.0%

Net income$40.3M+8.7%

EPS (diluted)$1.25+10.6%

Balance sheet

Cash & equivalents$72.9M+46.0%

Total debt$37.4M-1.7%

Total equity$1.3B+6.3%

Total assets$1.7B+4.7%

Cash flow

Operating cash flow$40.1M+9.9%

Valuation

Market cap$5.33B+0.5%

Enterprise value$5.3B+0.1%

P/E33.7×-5.1×

P/S5×-0.5×

Profitability

Gross margin36.3%+0.7pp

Operating margin20.2%+0.3pp

Net margin15%+0.8pp

FCF margin14.9%—

Returns & leverage

Return on equity12.7%+0.7pp

Debt / equity0×0.0×

Current ratio2.5×+0.1×

Where this comes from

Reported directly by Balchem in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: Balchem’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Balchem's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Balchem's indefinite-lived research and development assets?: Balchem (BCPC) reported indefinite-lived research and development assets of $0 in Q1 2026.